Comprehensive Assessment of Associations between ERCC2 Lys751Gln/Asp312Asn Polymorphisms and Risk of Non-Hodgkin Lymphoma |
Zhou, Jue-Yu
(Institute of Genetic Engineering, Southern Medical University)
He, Li-Wen (Institute of Genetic Engineering, Southern Medical University) Liu, Jie (Department of Gynaecology and Obstetrics, Nanfang Hospital, Southern Medical University) Yu, Hai-Lang (Institute of Genetic Engineering, Southern Medical University) Wei, Min (Institute of Genetic Engineering, Southern Medical University) Ma, Wen-Li (Institute of Genetic Engineering, Southern Medical University) Shi, Rong (Institute of Genetic Engineering, Southern Medical University) |
1 | Baris S, Celkan T, Batar B, et al (2009). Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma. Pediatr Hematol Oncol, 26, 467-72. DOI |
2 | Benhamou S, Sarasin A (2002). ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis, 17, 463-9. DOI ScienceOn |
3 | Berwick M, Vineis P (2000). Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst, 92, 874-97. DOI ScienceOn |
4 | Chiu BC, Weisenburger DD, Zahm SH, et al (2004). Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 13, 525-31. |
5 | Cochran W (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29. DOI ScienceOn |
6 | de Boer J, Hoeijmakers JH (2000). Nucleotide excision repair and human syndromes. Carcinogenesis, 21, 453-60. DOI |
7 | De Silva IU, McHugh PJ, Clingen PH, et al (2000). Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol, 20, 7980-90. DOI ScienceOn |
8 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI ScienceOn |
9 | Duan XL, Gong H, Zeng XT, et al (2012). Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 13, 3299-303. 과학기술학회마을 DOI |
10 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
11 | El-Din MA, Khorshied MM, El-Saadany ZA, et al (2013). Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt. Int J Hematol, 98, 681-6. DOI |
12 | Evans E, Moggs JG, Hwang JR, et al (1997). Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J, 16, 6559-73. DOI |
13 | Fabisiewicz A, Pacholewicz K, Paszkiewicz-Kozik E, et al (2013). Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients. Biomed Rep, 1, 151-5. |
14 | Friedberg EC (2001). How nucleotide excision repair protects against cancer. Nat Rev Cancer, 1, 22-33. DOI ScienceOn |
15 | Gillet LC, Scharer OD (2006). Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem Rev, 106, 253-76. DOI ScienceOn |
16 | Grulich AE, Vajdic CM, Cozen W (2007). Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 16, 405-8. DOI |
17 | Hartge PWS (2004). Overview of the etiology and epidemiology of lymphoma. In: Mauch PM, Armitage JO, Coiffier B, et al. (eds). Non-Hodgkin's Lymphomas. Lippincott Williams and Wilkins, New York, NY, pp711-27. |
18 | Itin PH, Sarasin A, Pittelkow MR (2001). Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol, 44, 891-920. DOI ScienceOn |
19 | Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
20 | Huang LM, Shi X, Yan DF, et al (2014). Association between ERCC2 polymorphisms and glioma risk: a meta-analysis. Asian Pac J Cancer Prev, 15, 4417-22. 과학기술학회마을 DOI |
21 | Kim HN, Kim NY, Yu L, et al (2014). Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma. Int J Mol Sci, 15, 6703-16. DOI |
22 | Li SX, Dai QS, Chen SX, et al (2014). Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis. Tumour Biol, 35, 3905-15. DOI |
23 | Liu D, Wu D, Li H, et al (2014). The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis. Gene, 538, 209-16. DOI |
24 | Lunn RM, Helzlsouer KJ, Parshad R, et al (2000). XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21, 551-5. DOI |
25 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
26 | Shen M, Purdue MP, Kricker A, et al (2007). Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica, 92, 1180-5. DOI |
27 | Sung P, Bailly V, Weber C, et al (1993). Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature, 365, 852-5. DOI |
28 | Shen M, Zheng T, Lan Q, et al (2006). Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet, 119, 659-68. DOI |
29 | Smedby KE, Lindgren CM, Hjalgrim H, et al (2006). Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev, 15, 258-65. DOI |
30 | Song B, Zhu JY, Liu J, et al (2008). Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 16, 97-100 (in Chinese). |
31 | Weber CA, Salazar EP, Stewart SA, et al (1990). ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. Embo j, 9, 1437-47. |
32 | Wood RD, Mitchell M, Sgouros J, et al (2001). Human DNA repair genes. Science, 291, 1284-9. DOI ScienceOn |
33 | Worrillow L, Roman E, Adamson PJ, et al (2009). Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma. Cancer Epidemiol, 33, 257-60. DOI |
34 | Xin Y, Hao S, Lu J, et al (2014). Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis. PLoS One, 9, 95966. DOI |
35 | Yan Y, Liang H, Light M, et al (2014). XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis. Tumour Biol, 35, 1907-15. DOI |
36 | Zhu HL, Bao JM, Lin PX, et al (2014). XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies. Asian Pac J Cancer Prev, 15, 6619-25. 과학기술학회마을 DOI |
37 | Yang F, Shi JY, Xu L, et al (2009). Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma. Zhonghua Xue Ye Xue Za Zhi, 30, 622-5 (in Chinese). |
38 | Yin QH, Liu C, Hu JB, et al (2013). XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 231-6. 과학기술학회마을 DOI |